Showing 41 - 60 results of 265 for search '"immunotherapeutic"', query time: 0.06s Refine Results
  1. 41
    Preferences for and drivers of adult vaccination clinic site selection: A cross-sectional study in 30 provinces in China

    Preferences for and drivers of adult vaccination clinic site selection: A cross-sectional study in 30 provinces in China by Yuxi Liu, Yanlin Cao, Yugang Li, Siyuan Liu, Yunshao Xu, Weizhong Yang, Luzhao Feng

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 42
    Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention

    Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention by Wenhui Hu, Han Feng, Ying Liu, Xiaoshuang Xu, Ping Zhou, Zhonghua Sun, Xinyu Tao, Jiahui Yang, Jun Wu, Chen Qu, Zhengxia Liu

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 43
    Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents

    Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents by Amparo L. Figueroa, Kashif Ali, Gary Berman, Wenqin Xu, Weiping Deng, Bethany Girard, Anne Yeakey, Karen Slobod, Jacqueline Miller, Rituparna Das, Frances Priddy

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 44
    Global research trends on biomarkers for cancer immunotherapy: Visualization and bibliometric analysis

    Global research trends on biomarkers for cancer immunotherapy: Visualization and bibliometric analysis by Yuan Qiao, Dong Xie, Zhengxiang Li, Shaohua Cao, Dong Zhao

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 45
    Considering the impact of vaccine communication in the COVID-19 pandemic among adults in Canada: A qualitative study of lessons learned for future vaccine campaigns

    Considering the impact of vaccine communication in the COVID-19 pandemic among adults in Canada: A qualitative study of lessons learned for future vaccine campaigns by Jeanna Parsons Leigh, Stephana Julia Moss, Jade MacDonald, Michal S. Cherak, Henry T. Stelfox, Ève Dubé, Kirsten M. Fiest, Donna M. Halperin, Sofia B. Ahmed, Shannon E. MacDonald, Sharon E. Straus, Terra Manca, Josh Ng Kamstra, Andrea Soo, Scott A. Halperin

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 46
    The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)

    The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV) by Adewunmi Akingbola, Abiodun Adegbesan, Olajumoke Adewole, Kolade Adegoke, Akpevwe Emmanuella Benson, Paul Ayomide Jombo, Sandra Uchechukwu Eboson, Victor Oluwasola, Ademola Aiyenuro

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 47
    Attitudes towards vaccination against COVID-19 during pregnancy and its determinants among people of reproductive age

    Attitudes towards vaccination against COVID-19 during pregnancy and its determinants among people of reproductive age by Chenyuan Qin, Yansheng Ding, Min Liu, Jue Liu

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 48
    Factors determining first influenza vaccination among individuals with type 2 diabetes in the CONSTANCES cohort by age group (younger than 65 years or 65 and older)

    Factors determining first influenza vaccination among individuals with type 2 diabetes in the CONSTANCES cohort by age group (younger than 65 years or 65 and older) by Sylvain Paquet, Virginie Ringa, Henri Panjo, Jeanne Sassenou, Marie Zins, Laurent Rigal

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 49
    Immunogenicity and safety of HepE Hecolin® in chronic hepatitis B patients at clinically stable stage: An open-label study in China

    Immunogenicity and safety of HepE Hecolin® in chronic hepatitis B patients at clinically stable stage: An open-label study in China by Li Zhang, Qiufen Zhang, Jiaye Liu, Wenlong Wu, Zechun Jiang, Bingyu Yan, Qingfan Cao, Haidong Liu, Huirong Pan, Jingjing Lv, Yi Feng, Fujie Xu, Shoujie Huang, Aiqiang Xu

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 50
    Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial

    Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial by Jelena Tica, Veronica V. Rezelj, Benoit Baron, Vitalija van Paassen, Javier Zaidman, Lee Fairlie, Gert Scheper, Mathieu Le Gars, Frank Struyf, Macaya Douoguih, Javier Ruiz-Guiñazú

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 51
    Hospital burden of pneumococcal disease in Spain (2016–2022): A retrospective study

    Hospital burden of pneumococcal disease in Spain (2016–2022): A retrospective study by Ruth Gil-Prieto, Valentín Hernandez-Barrera, Patricia Marín-García, Alba González-Escalada, Ángel Gil-de-Miguel

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 52
    Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India

    Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India by Nitin Shah, M.M.A. Faridi, Sheila Bhave, Apurba Ghosh, S. Balasubramanian, Vidya Arankalle, Raju Shah, Amar Jeet Chitkara, Arun Wadhwa, Jaydeep Chaudhry, Ramesh Srinivasan, M. Surendranath, Amita Sapru, Monjori Mitra

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 53
    Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies

    Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies by Anna R. Giuliano, Joel M. Palefsky, Stephen E. Goldstone, Jacob Bornstein, Ilse De Coster, Ana María Guevara, Ole Mogensen, Andrea Schilling, Pierre Van Damme, Corinne Vandermeulen, Misoo C. Ellison, Susan Kaplan, Jianxin Lin, Rachael Bonawitz, Alain Luxembourg

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 54
    Disease burden of influenza in Spain: A five-season study (2015–2020)

    Disease burden of influenza in Spain: A five-season study (2015–2020) by Iván Sanz-Muñoz, Irene Arroyo-Hernantes, Alejandro Martín-Toribio, Marina Toquero-Asensio, Javier Sánchez-Martínez, Carla Rodríguez-Crespo, Silvia Rojo-Rello, Marta Domínguez-Gil, Marta Hernández-Pérez, Eduardo Tamayo, Ruth Gil-Prieto, Ángel Gil-de-Miguel, José M Eiros

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 55
    Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial

    Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial by Siyue Jia, Chengwei Shao, Xin Cheng, Hongxing Pan, Zhijian Wang, Yu Xia, Jianfang Xu, Xuefen Huai, Danjing Leng, Jiarong Wang, Gan Zhao, Bin Wang, Jingxin Li, Fengcai Zhu

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 56
    Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial

    Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial by Xavier Sáez-Llorens, Rodrigo deAntonio, Eduardo López-Medina, Pío López, Taisei Masuda, Paul M Mendelman, Jim Sherwood, Frank Baehner, Astrid Borkowski

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 57
    Poison, lies, war: A mixed methods content analysis of posts about COVID-19 vaccination on Gab Social

    Poison, lies, war: A mixed methods content analysis of posts about COVID-19 vaccination on Gab Social by Alice Marianne Fritz, Andrea M. Smith

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 58
    Unreliable information and fear: Barriers to vaccination among IBD patients in China

    Unreliable information and fear: Barriers to vaccination among IBD patients in China by Jingwen Liu, Zelin Yan, Wen Hu, Shuyan Li, Yan Chen

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 59
    Rotavirus vaccine coverage, completion, and compliance: A systematic literature review

    Rotavirus vaccine coverage, completion, and compliance: A systematic literature review by Halima Tahrat, Ali Munir, Federico Marchetti

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 60
    Socioeconomic disparities in childhood vaccine hesitancy among parents in China: The mediating role of social support and health literacy

    Socioeconomic disparities in childhood vaccine hesitancy among parents in China: The mediating role of social support and health literacy by Xuelin Yao, Mao Fu, Jin Peng, Da Feng, Yue Ma, Yifan Wu, Liuxin Feng, Yu Fang, Minghuan Jiang

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: